SCHEMBL20127869

SCHEMBL20127869

Cc1cc(-c2ccccc2)c2c3ccccc3n(-c3ccccc3)c2c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ RXFP1 Q9HBX9 2/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ IL1R1 P14778 1/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ PLA2G2A P14555 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ BRCA1 P38398 1/20 0.37
▸ METAP2 P50579 1/20 0.37
▸ MAPK8 P45983 1/20 0.36
▸ PGR P06401 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22544332 0.84 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL18745063 0.84 KDM4E (0.36) L3MBTL1KDM4EATMRXFP1KMT2A
SCHEMBL17189842 0.83 KDM4E (0.55) L3MBTL1KDM4EATMRXFP1KMT2A
SCHEMBL22137157 0.82 L3MBTL1 (0.50) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL21730731 0.82 GAA (0.36) L3MBTL1KDM4EATMRXFP1KMT2A
SCHEMBL26271343 0.81 CNR2 (0.35) L3MBTL1KDM4EATMALDH1A1MAPT
SCHEMBL13086971 0.81 L3MBTL1 (0.57) L3MBTL1KDM4EATMKMT2AIL1R1
SCHEMBL13086978 0.81 L3MBTL1 (0.49) L3MBTL1KDM4EATMRXFP1KMT2A
SCHEMBL27264647 0.81 L3MBTL1 (0.40) L3MBTL1KDM4EATMRXFP1KMT2A
SCHEMBL18519192 0.80 L3MBTL1 (0.45) L3MBTL1KDM4EATMRXFP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3489249-B1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2021-06-09 — — EP disclosed
EP-3489249-A1 ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Samsung Electronics Co., Ltd. (KR) 2019-05-29 — — EP disclosed
US-20180130964-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING ORGANOMETALLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-05-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130964-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING ORGANOMETALLIC COMPOUND ORC3, OCIAD1, LEF1 L3MBTL1 123/4885KDM4E 2792/4885ATM 1634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback